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Abstract
Background: Dietary interventions are critical in the prevention of metabolic diseases. Yet, the effects of fatty fish
consumption on type 2 diabetes remain unclear. The aim of this study was to investigate whether a diet containing farmed
salmon prevents or contributes to insulin resistance in mice.
Methodology/Principal Findings: Adult male C57BL/6J mice were fed control diet (C), a very high-fat diet without or with
farmed Atlantic salmon fillet (VHF and VHF/S, respectively), and Western diet without or with farmed Atlantic salmon fillet
(WD and WD/S, respectively). Other mice were fed VHF containing farmed salmon fillet with reduced concentrations of
persistent organic pollutants (VHF/S-POPs). We assessed body weight gain, fat mass, insulin sensitivity, glucose tolerance, ex
vivo muscle glucose uptake, performed histology and immunohistochemistry analysis, and investigated gene and protein
expression. In comparison with animals fed VHF and WD, consumption of both VHF/S and WD/S exaggerated insulin
resistance, visceral obesity, and glucose intolerance. In addition, the ability of insulin to stimulate Akt phosphorylation and
muscle glucose uptake was impaired in mice fed farmed salmon. Relative to VHF/S-fed mice, animals fed VHF/S-POPs had less
body burdens of POPs, accumulated less visceral fat, and had reduced mRNA levels of TNFa as well as macrophage
infiltration in adipose tissue. VHF/S-POPs-fed mice further exhibited better insulin sensitivity and glucose tolerance than mice
fed VHF/S.
Conclusions/Significance: Our data indicate that intake of farmed salmon fillet contributes to several metabolic disorders
linked to type 2 diabetes and obesity, and suggest a role of POPs in these deleterious effects. Overall, these findings may
participate to improve nutritional strategies for the prevention and therapy of insulin resistance.
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Introduction
Insulin resistance is a critical defect in the pathogenesis of
obesity and type 2 diabetes. Alarmingly, the incidence of these
diseases has exploded worldwide, and is now reaching epidemic
proportions. In the United States, over 25% of adults are affected
by metabolic abnormalities associated with insulin resistance [1].
Similar situation has been documented in the European Union
where over half the adult population is estimated to be overweight
or obese [2]. In 20–25 years, 600 million people are expected to be
obese, and ,370 million persons will develop diabetes [3].
Dietary strategies have attracted extensive interest in our search
to halt and turn back the threat of insulin resistance-associated
metabolic diseases. However, the effectiveness of dietary ap-
proaches to prevent and treat metabolic disorders have remained
challenging [4,5]. During the last years, considerable focus has
been directed toward fatty fish and the influence of fish intake on
type 2 diabetes and other metabolic diseases remains ambiguous.
On one hand, very long-chain n-3 polyunsaturated fatty acids (LC
n-3 PUFA), primarily eicosapentaenoic acid (EPA) and docosa-
hexanoic acid (DHA), and fish protein have been documented to
protect against insulin resistance and cardiovascular disease [6–
11]. Furthermore, fish may also provide essential micronutrients
and bioactive compounds with potential health benefits [12,13].
On the other hand, recent studies reported that fish consumption
had no beneficial effects on the risk of type 2 diabetes and rather,
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enhanced the incidence of the disease [14–16]. We have, in
addition, demonstrated that the presence of environmental
contaminants, like persistent organic pollutants (POPs), in fish oil
may counteract the benefits of LC n-3 PUFA [17].
There are currently no published experimental data regarding
the metabolic impacts associated with intake of fatty fish as a whole
-combined effects of fish oil and fish meat-. In the present study,
we investigated whether farmed salmon fillet could protect against
the development of insulin resistance induced by a very high-fat
diet (VHF) or Western diet (WD) in mice. Furthermore, we
assessed whether the outcomes of salmon fillet intake could be
modulated by the presence of POPs.
Methods
Ethics statement
All experimental protocols were approved by the Norwegian
State Board of Biological Experiments with Living Animals
(authorization number: 1296, 1588, 2285).
Animal studies
Eight-week-old male C57BL/6J mice (Taconic, Ry, Denmark)
were housed on a 12 h light/dark cycle, with free access to food
and tap water. Mice were divided into weight matched groups and
fed either control (C; 2018 Teklad Global, Harlan Laboratories,
The Netherlands), VHF, VHF containing farmed salmon fillet
(VHF/S) or VHF containing farmed salmon fillet with reduced
POP concentrations (VHF/S-POPs) for 8 weeks. Level of protein in
the purified diets was adjusted to an isonitrogenous basis at the
expense of carbohydrates and corn oil was adjusted according to
lipids present in salmon fillet so that total dietary fatty acid
concentrations were similar in all purified diets (Table S1).
Accordingly, experimental diets contained (in ,percentage of
calories): 16% protein (casein with no added amino acids), 72% fat
(50% lard and 50% corn oil), and 12% carbohydrate (sucrose) for
VHF; 16% protein (salmon), 72% fat (50% lard, 19% corn oil, and
31% salmon oil from salmon fillet), and 12% carbohydrate
(sucrose) for both VHF/S and VHF/S-POPs. The energy content of
purified diets was measured in a bomb Parr calorimeter 6300 (Parr
Instruments, Moilne, IL, USA) and was found to be isocaloric
(,26.5 kJ/g).
In another set of experiments, mice were fed either chow low-fat
diet (C; D12450B Research Diet, Taconic, Gentofte, Denmark),
WD, or WD containing farmed salmon fillet (WD/S) for 6 weeks.
Purified diets contained 19% protein (casein with no added amino
acids), 29% fat (corn oil), and 52% carbohydrate (88% sucrose and
12% cornstarch) for WD; 19% protein (salmon), 29% fat (salmon
oil from salmon fillet), and 52% carbohydrate (88% sucrose and
12% cornstarch) for WD/S. Energy content of both WD and
WD/S was ,20.5 kJ/g.
All purified diets were supplemented with cellulose, choline
bitartrate, AIN vitamin mixture 76, and AIN mineral mixture 76
as described previously [17]. Once made, experimental purified
diets were screened for POP concentrations (Table S2).
Casein (no added amino acids), lard, cellulose, choline
bitartrate, AIN vitamin mixture 76, and AIN mineral mixture
76 were purchased from MP Biomedicals (Illkrich, France), corn
oil was from Landlord (Reitangruppen, Denmark), cornstarch was
from Primeal (Peaugres, France), and sucrose was from Dan
Sukker (Oslo, Norway).
Salmon fillets
Commercial farmed Atlantic salmon fillets were bought from an
international fish retailer (Leroy Seafood Group, Bergen, Norway).
To reduce the presence of POPs in farmed salmon fillet, we
tailored Atlantic salmon by feeding them a standard fish feed in
which the fish oil used was purified rather than crude; crude fish
oil being the principal source of POPs in fish feed [18]. Through
this approach, we managed to produce farmed salmon fillet with
,50% lower POP concentrations compared with commercial
farmed salmon fillet (Table S3). After 8 weeks, Atlantic salmon
(11376215 g, n=36) were filleted. Both commercial and tailored
farmed salmon fillets were then freeze dried and homogenised.
Before being used for animal studies, homogenised salmon fillets
were analyzed for crude protein level with a Leco FP-528 nitrogen
analyzer (Leco Corp, St. Joseph, MI, USA), amino acid levels were
assessed with Acquity Ultraperformance LC (Waters, Milford,
Massachusetts, USA), lipid content and fatty acid composition
were analysed as described previously [17,19]. Characteristics of
salmon fillets are shown in Table S3.
POP analysis
Concentrations of organochlorine pesticides, dioxins, furans,
dioxin-like polychlorinated biphenyls (dl-PCBs), and 7 polychlori-
nated biphenyls (7PCBs; PCB28,52,101,138,153,180) were mea-
sured as described previously [17].
Tissue harvest
Overnight fasted animals were anaesthetized with isoflurane.
Organs were dissected, weighed, dipped in liquid nitrogen, and
stored at 280uC until further analysis. Other tissues were fixed for
histological investigations.
Assessment of triacylglycerol (TAG) levels
Concentrations of TAG were determined in gastrocnemius
muscle and liver (left lobe) samples of overnight-fasted mice as
described previously [17].
Assessment of fat absorption
Three weeks before the end of experiments, feces present in
cages were collected over a period of 7 days. After collection, feces
were dried, weighed, and total lipid was extracted from feces by
homogenization in chloroform:methanol, (2:1, v/v) with 19:0
methyl ester as internal standard as reported previously [20].
Histology and immunohistochemistry
Small pieces of epididymal or liver (left lobe) fat were fixed
overnight at 4uC by immersion in phosphate buffered 4%
paraformaldehyde. Next, samples were dehydrated and embedded
in paraffin. Hematoxylin and eosin (H&E) staining was performed
on 5 mm thick sections to assess morphology. Other 5 mm sections
were deparafinized, rehydrated and endogenous peroxide was
inactivated by 3% hydrogen peroxide. To reduce non-specific
staining the sections were incubated in heat-inactivated normal
goat serum (10%, 10 min). Sections were then incubated overnight
at 4uC with rat anti-mouse F4/80 (1:500; AbD Serotec, Oxford,
England), and then incubated ith rat anti-goat-IgG (1:250; AbD
Serotec, Oxford, England) conjugated with horseradish peroxidase
for 2 h. Specific binding was visualised using diaminobenzidine.
Plasma insulin and blood glucose
We collected blood from the tail vein of conscious animals one
week before the end of feeding trial. Plasma insulin concentrations
were assessed by ELISA (Mouse Insulin ultrasensitive ELISA,
DRG, Marburg, Germany). Blood glucose levels were measured
with a glucometer (Ascensia Contour, Bayer Healthcare, Oslo,
Norway).
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Insulin and glucose tolerance tests
Insulin and glucose tolerance tests were performed in fed and 5 h
fasted mice, respectively. At week 7 and 5 for VHF and WD trials,
respectively, mice were injected i.p. with human insulin (Actrapid,
Novo Nordisk, Bagsværg, Denmark; 1.0 U/kg body weight) or
glucose (1.0 mg/g body weight), and blood glucose was measured
prior to injection and at 15, 30, 60, and 90 min after injection.
Assessment of insulin secretion
One week before the end of feeding trial, 5 h fasted mice were
injected i.p. with 2 mg glucose/g body weight and plasma insulin
measured at 0 and 15 min post-injection.
Insulin signaling
In vivo insulin stimulation was performed as described previously
[21], with minor modifications. Overnight fasted animals were
injected i.p. with saline or human insulin (20 U/kg body weight),
and 10 min later, whole gastrocnemius muscles (both white and
red parts) were harvested, frozen in liquid nitrogen, and stored at
280uC. Frozen muscle samples were weighed, homogenised and
Akt/phospho-Akt (Ser473) was measured by immunoblotting as
described previously [22]. Each sample was run at least three
times. Antibody binding was detected by enhanced chemilumi-
nescence (ECL; Amersham Pharmacia, Biotech, Buckingham-
shire, UK). For semi-quantification of immunoblots, chemilumi-
nescence imaging was assessed by G:Box system with Gene Snap
software, and images were analyzed by Gene Tool software
(Syngene, Cambridge, England). Primary and secondary antibod-
ies were from Cell Signaling (Beverly, MA, USA).
Ex vivo muscle glucose uptake
Glucose uptake was assessed in intact soleus muscle, a small thin
slow-twitch muscle, incubated without or with insulin (60 nmol/l)
as described previously [22].
Adipocyte differentiation
3T3-L1 preadipocytes were grown to confluence in standard high
glucose Dulbecco’s modified Eagle’s medium (DMEM; PAA, Les
Mureaux, France) supplemented with 10% bovine serum (PAA) at
37uC in a humidified atmosphere of 5% CO2. Two days after
reaching confluence, differentiation was initiated by incubation in
DMEM supplemented with 10% fetal bovine serum, FBS (PAA),
10 mg/ml insulin (Sigma-Aldrich, Saint-Quentin Fallavier, France),
50 nM cortisone (Sigma-Aldrich) to avoid maximal differentiation
[23], and 0.5 mM isobutylmethylxanthine (Sigma Aldrich). After
two days, the medium was removed and the cells were cultured for
three additional days in DMEM containing 10% FBS and insulin
supplemented or not with different concentrations of pp9-dichlor-
odiphenyldichloroethylene (pp9-DDE; Sigma Aldrich). The medi-
um was then removed and the cells were maintained in 10% FBS
medium alone without pp9-DDE for two days. Lipid accumulation
was quantified using Oil Red O staining. Oil red O was dissolved in
isopropanol overnight at a concentration of 0.35% followed by
filtration, dilution in water to a final concentration of 0.2%.
Differentiated adipocytes were washed with PBS and fixed in 10%
formalin for 60 min. After washing, cells were stained with Oil Red
O for 10 min at room temperature. Following washes, cells were
dried and Oil Red O was eluted by 100% isopropanol and
absorbance was measured at 500 nM.
Quantification of mRNAs using real-time PCR
Total RNA was prepared from epididymal fat, and real-time
PCR assays were performed as described previously (17). Briefly,
first-strand complementary DNA’s (cDNAs) were first synthesized
from 250 ng of total RNA in the presence of 100 units of
Superscript II (Invitrogen, Eragny, France) using a mixture of both
random hexamers and oligo (dt) primers. The real-time PCR was
performed with a Rotorgene Q (Qiagen, Courtaboeuf, France) in
a final volume of 20 ml containing 5 ml of a 60-fold dilution of the
RT reaction medium, and 15 ml of reaction buffer from the
ABsolute QPCR SYBR Green Mix (Thermo Scientific). For
quantification, a standard curve was systematically generated with
6 different amounts (150 to 30,000 molecules/tubes) of purified
target cDNA cloned in the pGEM plasma (Promega, Charbon-
nie`res, France). Each assay was performed in duplicate. Data were
normalized using TATA Box Binding protein (TBP) mRNA levels
measured in each sample by real-time PCR as an internal
standard and then expressed as arbitrary unit (AU). Primer
sequences are available upon request (hubert.vidal@univ-lyon1.fr).
Statistics
Results are expressed as mean 6 SE. Differences between
groups were examined for statistical significance using analysis of
variance (ANOVA) with the least-square difference (LSD) post hoc
test. Repeated measures ANOVA was used on data obtained from
tolerance tests. When appropriate, statistical significance was
determined using Student’s t test. Differences were considered
significant at p,0.05.
Results
Intake of farmed salmon fillet causes visceral obesity and
chronic-low grade inflammation in adipose tissue of mice
fed VHF
VHF feeding was reported to develop a diabetic phenotype
before the onset of obesity in mice [24]. We took advantage of this
dietary model and investigated the impacts of farmed salmon fillet
intake in VHF-fed mice. After 8 weeks, mice fed VHF/S gained
about two times more weight than other animals (Figure 1A)
despite similar energy intake (Figure 1B). Interestingly, VHF/S-fed
mice were characterized by enhanced fat absorption as demon-
strated by reduced fat excretion in feces (Figure S1), a mechanism
that likely participated to increase body weight gain of these
animals. In association with their increased body weight, animals
fed VHF/S exhibited increased visceral fat (Figure 1C), which was
associated with a prominent increased of adipocyte size in
epididymal fat pad (Figure 1D). Furthermore, the expression of
Mac2-a, a galactose-binding lectin expressed by activated macro-
phages, was increased by about 13-fold in epididymal fat of
animals fed VHF/S compared with VHF (Table 1), thereby
suggesting macrophage infiltration in adipose tissue of animals
exposed to farmed salmon fillet. Because activated macrophages
may release inflammatory molecules, we next measured expression
of IL-6, iNOS, and TNFa. In white adipose tissue of mice fed
VHF/S, mRNA levels of TNFa and iNOS were up-regulated by
about 5- and 3-fold, respectively, compared with VHF-fed mice
whereas IL-6 expression was unchanged (Table 1). In concert,
these results indicated that farmed salmon feeding robustly
increases body weight and fat mass, and induces chronic-low
grade inflammation.
Intake of farmed salmon fillet exaggerates insulin
resistance and glucose intolerance in mice fed VHF
We next examined glucose homeostasis of animals by
challenging them to a glucose tolerance test. In comparison with
C-fed mice, mice fed VHF had higher blood glucose levels at all
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Figure 1. Mice fed VHF/S developed obesity and insulin resistance. In two separate studies, mice fed C (n= 14), VHF (n= 43) or VHF/S diet
(n= 38) were monitored for 8 weeks and assayed for various metabolic parameters. (A) Body weight gain (14–43 mice per group). (B) Energy intake
(14–43 mice per group). (C) Quantification of adipose tissue. Total fat pad includes epididymal, retroperitoneal and inguinal fat pad (7–16 mice per
Fatty Fish, POPs and Metabolic Disorders
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time points following the glucose load (Figure 1E), thereby
confirming the diabetic phenotype of VHF-fed mice despite the
absence of obesity. Importantly, dysregulation of whole-body
glucose homeostasis was worsen in mice fed VHF/S (Figure 1E),
and was associated with increased insulin production in response
to glucose challenge (Figure 1F). VHF/S-fed mice also exhibited a
reduced response to glucose clearance following insulin load
relative to VHF- and C-fed mice (Figure 1G); all features
demonstrating a state of insulin resistance. Accordingly, mice fed
VHF/S had increased blood glucose (Figure 1H) and plasma
insulin (Figure 1I) relative to other animals. Because skeletal
muscle is a predominant peripheral site of insulin-dependent
glucose disposal [25], we further investigated insulin-stimulated
glucose uptake in soleus muscles of animals. In the absence of
insulin, basal muscle glucose uptake was similar in all experimental
groups (Figure 1J). However, the ability of insulin to stimulate
glucose uptake was reduced in muscles of mice fed VHF (-22%)
and VHF/S (-47%) compared with C-fed mice (Figure 1J). In
accordance with these results, we found that insulin-stimulated
phosphorylation of Akt, a key insulin signaling protein, was
decreased in skeletal muscles of both VHF and VHF/S-fed mice
relative to animals fed control diet (Figure 1K). Loss of insulin
action in skeletal muscles was associated with enhanced muscle
TAG accumulation (Figure 1L), which is consistent with previous
report [26]. Furthermore, the development of hepatic steatosis,
which is a severe manifestation of metabolic syndrome, was also
exacerbated in mice fed farmed salmon fillet (Figure S2). By using
F4/80 staining, no mature macrophage infiltration was found in
livers of VHF/S-fed mice (data not shown). Altogether, these data
demonstrated that intake of farmed salmon fillet caused visceral
obesity and accelerated the development of insulin resistance
induced by VHF feeding.
Intake of farmed salmon fillet contributes to visceral
obesity and insulin resistance mice fed WD
To confirm the ability of farmed salmon fillet to induce insulin
resistance and visceral obesity in a more conventional experimen-
tal diet inducing both insulin resistance and obesity, we challenged
animals with high-fat/high-carbohydrate diet; WD. After 6 weeks,
mice fed WD/S had higher body weight gain than mice fed WD
and C (Figure 2A) despite similar energy intake (Figure 2B). As
observed under VHF feeding, the percentage of fat excreted in
feces was largely reduced in mice fed WD/S relative to WD
(Figure S3), thereby suggesting increased intestinal fat absorption
in WD/S-fed mice. Consistent with enhanced body weight, mice
fed WD/S were characterized by an overgrowth of adipose tissue,
including epididymal, retroperitoneal and inguinal fat pad
(Figure 2C), and was associated with adipocyte hypertrophy and
macrophage infiltration (Figure 2D). Next, we assessed glucose
tolerance and insulin sensitivity of animals. In fasted state, there
were no differences in blood glucose (Figure 2E) and plasma
insulin concentrations (Figure 2F). However, in fed condition, a
mild increase of blood glucose (Figure 2E) and dramatic increase
in plasma insulin levels (Figure 2F) was found in mice challenged
with WD/S, suggesting a whole-body insulin resistance state. In
accordance, both glucose and insulin tolerance tests revealed that
animals fed WD/S had impaired glucose tolerance (Figure 2G)
and systemic insulin resistance (Figure 2H). Furthermore, insulin-
stimulated glucose uptake in skeletal muscles was significantly
reduced in WD/S-fed mice (Figure 2I), and correlated with
increased muscle TAG storage (Figure 2J). Elevated TAG
concentrations in liver of animals fed WD/S were also found
(Figure S2). Taken together, these results demonstrated that mice
fed WD/S, similarly to animals fed VHF/S, developed serious
disorders linked to type 2 diabetes and obesity.
Potential implications of POPs in the deleterious
metabolic effects associated with farmed salmon intake
We have previously reported that POPs may counteract the
benefits of salmon oil and impair insulin action in both in vivo and
in vitro models [17]. To determine whether the presence of POPs
modulates the outcomes of farmed salmon fillet intake, we
compared the metabolic profile of mice challenged with VHF/S
to those fed VHF/S-POPs (Table S1 and S2). In epididymal fat,
mice fed VHF/S-POPs had about 20% and 50% lower concentra-
tions of 7PCBs and dichlorodiphenyltrichloroethanes (DDTs),
respectively, than animals fed VHF/S (Figure 3A), thereby
indicating that mice fed VHF/S-POPs had reduced body burdens
of POPs. Interestingly, mice fed VHF/S-POPs had reduced body
weight gain (Figure 3B) and visceral fat compared with animals fed
VHF/S (Figure 3C). This decrease in adipocity was correlated
with reduced adipocyte size and macrophage infiltration as
revealed by H&E and F4/80 staining (Figure 3D), as well as
reduced Mac2-a expression (Figure 3E). In addition, mRNA levels
of TNFa, but not IL-6 and iNOS, in white adipose tissue of mice fed
VHF/S-POPs were significantly down-regulated compared with
VHF/S-fed mice (Figure 3E). There were no significant
differences in energy intake and fat absorption between groups
(data not shown).
Further, we investigated whether mice fed VHF/S-POPs had
comparable glucose intolerance and insulin resistance to animals
fed VHF/S. In fasted state, blood glucose tended to decrease in
Table 1. Expression of inflammatory markers in epididymal
fat of animals.
Inflammatory genes (arbitrary units) VHF VHF/S
Mac2-a 2.660.4 34.468.0
IL-6 7.463.5 6.560.9
TNFa 5.861.6 35.367.6
iNOS 3.860.5 11.961.8
doi:10.1371/journal.pone.0025170.t001
group). (D) H&E staining showing representative morphology of adipocyte in epididymal fat of animals (4–5 mice per group). (E) Glucose tolerance
test. Glucose was injected and blood glucose was assessed at indicated time points (7–13 mice per group). (F) Glucose-stimulated insulin release.
Plasma insulin levels were measured before and 15 min after injection of glucose in mice (8–12 mice per group). (G) Insulin tolerance test. Random-
fed mice were injected with insulin and blood glucose assessed at indicated time points (7–13 mice per group). (H) Blood glucose (4–7 mice per
group) (I) Plasma insulin (4–6 mice per group). (J) Muscle glucose uptake. Ex vivo soleus muscles were incubated without or with insulin and glucose
uptake assessed (7–12 mice per group). (K) In vivo insulin signaling. Overnight fasted animals (n = 4–5 per group) were injected with insulin or saline
and expression of Akt and pAkt in gastrocnemius muscles was assessed. Graphic depicts densitometric analysis of normalization of pAkt/Akt protein.
Representative western blots of muscle lysates are shown for phosphorylated Akt (Ser473) without or with insulin stimulation, and for total Akt
expression after saline injection. Western blot analyses were repeated at least three times. (L) Triacylglyceride (TAG) concentrations in gastrocnemius
muscles (6–12 mice per group). *p,0.05 vs. C. **p,0.03 vs. VHF.
doi:10.1371/journal.pone.0025170.g001
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VHF/S-POPs relative to VHF/S-fed animals (7.160.6 vs.
8.360.6 mmol/l, respectively), whereas plasma insulin concentra-
tions were significantly reduced in mice challenged with VHF/S-
POPs compared with VHF/S (137.5617.4 vs. 175.7610.44 pmol/
l, respectively). Following glucose injection, blood glucose response
was similar between mice fed VHF/S and VHF/S-POPs (Figure 3F)
whereas glucose-stimulated insulin production was reduced in
mice fed VHF/S-POPs (Figure 3G). Furthermore, mice fed VHF/S-
POPs had a tendency to better whole-body insulin sensitivity
following insulin load (Figure 3H). To investigate this further, we
measured ex vivo muscle glucose uptake. Consistent with enhanced
insulin action, animals consuming VHF/S-POPs had improved
insulin-stimulated glucose uptake in soleus (Figure 3I), which was
accompanied by reduced muscle TAG accumulation (Figure 3J),
and tended to have less hepatic TAG concentration (Figure S2).
Overall, these results highlight that POPs may affect the metabolic
impacts induced by farmed salmon fillet intake. To further confirm
a causal role of POPs in metabolic disorders, especially in adipose
tissue related disorders, we investigated the ability of pp9-DDE, the
DDT congener most present in salmon fillet, to stimulate lipid
accumulation in 3T3-L1 cells. In this murine cell line, exposure to
pp9-DDE was found to enhance lipid accumulation compared
with vehicle-treated cells (Figure 3K). This finding highlights the
ability of this organochlorine pesticide to regulate adipose tissue
biology, and extends our previous observations that exposure to
DDT mixture containing pp9-DDE impairs insulin action and
glucose uptake in 3T3-L1 cells [17].
Discussion
In the present study, we reported that inclusion of farmed
salmon fillet in two different experimental diets, VHF and WD,
contributed to insulin resistance and obesity in mice. Furthermore,
our data suggested that the presence of POPs may participate to
the deleterious metabolic outcomes associated with farmed salmon
fillet intake.
The impacts of fatty fish consumption on chronic and metabolic
diseases remain unclear. Intake of fish and LC n-3 PUFA was
reported to either ameliorate [9,27,28], have no effect [29-33], or
impair [34–39] glycemic control and insulin sensitivity. Further-
more, intake of LC n-3 PUFA was found to enhance the risk of
diabetes in older women [40]. This finding was recently supported
by three prospective follow-up studies. In the United States, after a
,3 million person-years of follow up, LC n-3 PUFA and fish
consumption was reported to enhance the incidence of type 2
diabetes [15]. In accordance, a ,12 years follow-up of American
women highlighted a positive association between fatty fish and
LC n-3 PUFA consumption and type 2 diabetes [16]. In Europe, a
15 years of follow-up investigation revealed a positive association
for fish intake and diabetes risk in Dutch adults [14]. Consistent
with these findings, we provide here the first experimental
evidence that diet containing fatty fish -farmed Atlantic salmon
fillet- may cause, in rodents, several disorders associated with type
2 diabetes and obesity.
Identification of mechanisms behind the deleterious effects of
farmed salmon fillet remains challenging because fatty fish
represents a complex food matrix. There is emerging evidence
suggesting that environmental contaminants like POPs may
modulate the health effects of seafood consumption. Lipophilic
POPs are mainly present in the lipid fraction of fish and their
concentrations are therefore expected to be higher in fatty fish
than in lean fish. Interestingly, delipidated salmon protein
hydrolysate and cod fillet (,0.2% lipid) were found to prevent
the development of insulin resistance in obese rats fed high-fat diet
[10,12], thereby highlighting that fish protein, with very low
concentrations of lipids and POPs, may have beneficial effects. In
addition, we have reported that consumption of salmon oil with
very low POP levels protected against insulin resistance and
visceral obesity in rats, whereas intake of similar oil containing
environmental levels of POPs contributed to the development of
metabolic disorders [17]. In the present study, we further
demonstrated that glucose and lipid homeostasis was less disturbed
in mice fed VHF/S-POPs relative to mice fed VHF/S, thereby
suggesting that POPs may affect the outcomes of fatty fish, i.e.
both fish protein and fish oil. In addition, we found that pp9-DDE
interacted with adipose tissue biology, which is in line with the
established endocrine disruptor features of xenobiotics [41–43]. In
concert, these findings suggest that inconsistency of studies
investigating the impacts of fish products and LC n-3 PUFA on
metabolic diseases may, in part, be ascribed to the different
concentrations of POPs present in fish and marine oils.
Although people are regularly advised to consume healthy and
varied food products as well as to exercise, the global prevalence of
chronic metabolic diseases continues to increase at alarming rates.
This worrying situation clearly reflects the urgency to optimize
current dietary and lifestyle strategies to fight insulin resistance and
obesity. During the last years, several studies reported that diabetes
is associated with increased body burdens of POPs [44–46], and a
recent study further highlighted a potential implication of POPs in
the development of obesity in humans [47]. Numerous toxicolog-
ical studies have also documented that single environmental
pollutant may act as endocrine disruptor [41,43]. However, no
experimental study has documented the metabolic effects
associated with the consumption of multiple POPs present in a
whole food matrix. This issue is of particular interest since humans
are mainly exposed to POPs through intake of animal food
products like fatty fish, dairy products, and meat [48]. Here, we
provide the first evidence that exposure to various POPs through
intake of farmed salmon, one of the most consumed fatty fish
worldwide, may participate to metabolic disorders linked to type 2
diabetes and obesity. In addition, it appears that environmental
doses of POPs are sufficient to provoke harmful effects because
concentrations of 7PCBs in adipose tissue of animals fed farmed
salmon fillet were similar to those observed in the general
Figure 2. Intake of WD/S exacerbated obesity and insulin resistance. In two separate studies, mice fed C (n= 8), WD (n=15) or WD/S (n=15)
diet were monitored for 6 weeks. (A) Body weight gain (8–15 mice per group). (G) Energy intake (8–15 mice per group). (C) Quantification of adipose
tissue. Total fat pad includes epididymal, retroperitoneal and inguinal fat pad (4–6 mice per group). (D) Representative H&E staining (upper panel)
and immunohistochemical detection of the macrophage-specific antibody F4/80 (lower panel) in epididymal fat (4–5 mice per group). Note the
abundance of macrophages (arrows) surrounding adipocytes, crown-like structures, in epididymal fat of WD/S-fed animals. (E) Blood glucose and (F)
plasma insulin was determined in random-fed and fasted mice (4–7 mice per group). (G) Glucose tolerance test. Glucose tolerance test was
performed by injection of glucose in fasted mice and blood glucose was assessed at indicated time points (4–7 mice per group). (H) Insulin tolerance
test. Insulin tolerance test was performed by injection of insulin in random-fed mice and blood glucose was assessed at indicated time points (4–7
mice per group). (I) Muscle glucose uptake. Glucose uptake was assessed in ex vivo soleus muscles incubated without or with insulin (4–6 mice per
group). (J) TAG concentrations in gastrocnemius muscles (4-6 mice per group). *p,0.05 vs. C. **p,0.04 compared with WD.
doi:10.1371/journal.pone.0025170.g002
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population, whereas DDT concentrations were below the human
baseline average levels [49,50]. These results are in accordance
with human studies showing that low and environmental doses of
POP exposure may increase the risk of insulin resistance [46,47].
Altogether, these data strongly suggest that human exposure to
environmental pollutants has significantly contributed to the
epidemic of metabolic syndrome. Limitation of daily and long-
term exposure to POPs may therefore represent a novel and
attractive approach to slow down the uncontrolled rise of
metabolic diseases.
In summary, this study demonstrates that chronic intake of
farmed fatty fish contributes, rather than prevents, to insulin
resistance and obesity and that these negative effects are, in part,
mediated by the presence of POPs in fatty fish. Whether common
food products containing POPs like meat and milk products
induce unhealthy effects in similar or other dietary models requires
further investigations. In addition, future studies should investigate
the metabolic impacts of moderate POP-containing farmed
salmon consumption –two-three times per week- over long-term.
Overall, our findings may provide novel insights regarding future
human and clinical nutrition strategies aimed at preventing or
treating type 2 diabetes and obesity.
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